Decoding the Labs
“The Three Fraud Departments”
The Big Picture
Picture a massive bank — not your neighborhood branch, but a 24/7 financial network where trillions of transactions flow every second. This bank is your bloodstream. Red blood cells are the armored trucks carrying oxygen-cash to every organ. Platelets are the security team, rushing to seal any breach in the vault walls. And the coagulation cascade? That’s the bank’s fraud detection system — a sophisticated network of checkpoints designed to stop unauthorized withdrawals.
Now imagine the fraud detection system goes rogue. It starts flagging legitimate transactions as suspicious. Accounts get frozen. Money stops flowing. That’s Antiphospholipid Syndrome — and the rogue detectors are the aPL antibodies.
But here’s the thing about a rogue fraud department: you can’t fix it until you figure out which detectors are malfunctioning. This bank has three fraud departments, each using different methods to scan for problems. Your job? Identify which ones have gone rogue.
What are the three types of aPL antibodies, how do we detect each one, and why does this matter for APS diagnosis?
Core Content — The Three Fraud Departments
The Comparison Table
| Feature | LA (Speed Monitor) | aCL (Pattern Scanner) | Anti-β2GPI (Investigator) |
|---|---|---|---|
| Method | Functional (coag assay) | ELISA (immunoassay) | ELISA (immunoassay) |
| Measures | What the system DOES | Antibodies on paperwork | The actual target |
| On anticoagulation? | ❌ Cannot test | ✅ Can test | ✅ Can test |
| Specificity for APS | Highest | Moderate | High |
| Thrombosis prediction | Strongest | Moderate | Strong |
| Key threshold (2023) | Positive/Negative | IgG ≥40, IgM ≥80 | Domain I positivity |
Triple Positivity — The Grand Slam
When ALL THREE departments report the same person… when the Transaction Speed Monitor flags a slowdown, the Pattern Scanner finds suspicious paperwork, AND the Identity Investigator confirms the culprit’s identity — that’s triple positivity. The case is airtight.
Clinically, these patients face the highest thrombotic risk: 5–10% per year. They are the patients who absolutely cannot use DOACs (the TRAPS trial — Module 3). Triple positivity is the “grand slam” of aPL profiling.
The 12-Week Confirmation Rule
The bank doesn’t act on a single report. What if the detector malfunctioned once? A transient infection can trigger temporary aPL positivity — the system threw a false alarm. That’s why the 2023 criteria require confirmation at least 12 weeks apart: two independent investigations, same conclusion. Never diagnose APS on a single positive test.
Board Pearls
LA is in vitro anticoagulant, in vivo procoagulant. In your lab coagulation assays, LA slows clotting. In the patient’s blood vessels, it causes clots. Know this backwards and forwards.
Mix and Fix = Deficiency; Mix and Miss = Inhibitor. If aPTT corrects with mixing (Fix), it’s a factor deficiency. If it stays prolonged (Miss), it’s an inhibitor — LA positive.
Triple Positive = Highest Risk (5–10%/yr). LA + aCL + anti-β2GPI all positive = the grand slam. These patients need warfarin, never DOACs.
12-Week Confirmation Rule. Never diagnose APS on a single positive test. Confirm at ≥12 weeks. Transient positivity from infections is common.
Chromogenic Factor X Assay. LA interferes with INR monitoring. Use chromogenic factor X assay instead of PT to monitor warfarin in LA-positive patients.
Memory Aids
“LA: Liar in the Lab, Assassin in the Artery” — In vitro anticoagulant, in vivo procoagulant.
“Mix and Fix / Mix and Miss” — Fix = deficiency corrects. Miss = inhibitor persists.
“LA lies about the INR — X marks the spot” — Use chromogenic factor X assay to monitor warfarin in LA-positive patients.
“Triple Positive = Grand Slam = Highest Risk”
“12 Weeks or It Doesn’t Count” — Single positive is not APS.
Test Yourself
Q1: A 32-year-old woman with recurrent DVTs has a prolonged aPTT. A mixing study is performed and the aPTT does NOT correct. What is the next step?
Show AnswerQ2: A patient with known APS and LA positivity on warfarin has an INR of 3.8 but doesn’t appear over-anticoagulated. What’s happening?
Show AnswerQ3: Which aPL antibody profile carries the highest thrombotic risk?
Show AnswerSummary
- The three aPL antibodies are LA (functional assay), aCL (ELISA), and anti-β2GPI (ELISA)
- LA is the strongest thrombosis predictor but cannot be tested on anticoagulation
- aCL and anti-β2GPI CAN be tested on anticoagulation
- Triple positivity = highest risk (5–10%/year) = warfarin mandatory
- Always confirm at ≥12 weeks — never diagnose on a single positive
- Use chromogenic factor X assay for INR monitoring in LA-positive patients